A Multicenter Cohort Study of Dose-Dense Temozolomide (21 of 28 Days) for the Treatment of Recurrent Anaplastic Astrocytoma or Oligoastrocytoma

Author: Neyns Bart   Chaskis Cristo   Joosens Eric   Menten Johan   D'Hondt Lionel   Branle Fabrice   Sadones Jan   Michotte Alex  

Publisher: Informa Healthcare

ISSN: 0735-7907

Source: Cancer Investigation, Vol.26, Iss.3, 2008-03, pp. : 269-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content